Therapeutic effects of PTCD and ERCP in patients with obstructive severe acute biliary pancreatitis

1. Introduction

Acute pancreatitis (AP) is a common clinical emergency and a heterogeneous condition with the potential for significant morbidity and mortality^[1]. In the past few years, incidences of first-time acute pancreatitis and disease-related complications have been increasing^[2]. Acute biliary pancreatitis (ABP) accounts for 50%-70% of acute pancreatitis incidences^[3]. The etiology of ABP is complex and multifactorial. Gallstones are the main cause of acute pancreatitis^[4,5]. Severe acute pancreatitis is characterized by persistent single or multiple organ failure, which is associated with mortality rates between 20% and 40%^[6-9]. About 20% of acute pancreatitis patients exhibit severe acute pancreatitis episodes. Determinant-based classification^[10] (DBC) and revised Atlanta classification^[7] (RAC) support severe acute pancreatitis is characterized by local or systemic complications and persistent organ failure (POF^[11]>48 h) (cardiovascular, respiratory, and renal system).

Even though early management of different degrees and reasons of pancreatitis is majorly focused on fluid resuscitation, removal of biliary obstruction is advocated for obstructive severe acute biliary pancreatitis (SABP)^[12]. Biliary obstruction can be removed via endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic cholangial drainage (PTCD) and surgical treatment. ERCP is the primary option for ABP patients with acute cholangitis^[13]; however, the 2013 IAP/APA guidelines^[14] suggest that there is no evidence for optimal timing of ERCP treatment for biliary pancreatitis patients without cholangitis. With regards to treatment timing of ERCP, the 2015 Italian consensus guidelines^[11,15] on severe acute pancreatitis recommend that when biliary obstruction is confirmed, ERCP should be performed within 72 h of admission. However, the 2019 ASGE guidelines^[16] on the role of endoscopy in evaluation and management of choledocholithiasis suggest the emergency (within 48 h) ERCP is recommended for biliary pancreatitis patients with biliary obstruction or bile duct stones. The guidelines and meta-analyses data show that a suitable time for endoscopy treatment of severe acute biliary pancreatitis is incoherent.

PTCD is widely accepted as an alternative to operative decompression in patients with cholangitis or cholecystitis, particularly elderly patients^[17-19] and SABP patients who cannot tolerate endoscopy^[20] or for whom endoscopy is unsafe^[21]. A retrospective study^[22] involving 64 patients with obstructive SABP revealed that laboratory indicators and APACHE-II scores were decreased after early PTCD. However, there is insufficient evidence to support the effects of ERCP and PTCD in improving the clinical efficacies, such as laboratory indices, hospitalization stays, recovery of liver functions, remission of abdominal pain and complications. Moreover, appropriate therapeutic timing of ERCP and PTCD for obstructive SABP patients has not been established.

Thus, the efficacies of PTCD and ERCP in early treatment of obstructive SABP should be investigated. We retrospectively analyzed the clinical data for patients with obstructive SABP to evaluate the therapeutic effects of obstruction relieving by PTCD and ERCP as well as the therapeutic timing during interventions.

2. Methods

2.1. Patients and data collection

Patients from Beijing Tiantan Hospital who met the inclusion criteria (Table 1) were included in this study. The institutional research ethics committee of Beijing Tiantan Hospital, Capital Medical University approved this study. Clinical data for 62 patients with obstructive SABP were retrospectively analyzed at Beijing Tiantan Hospital, China, from July 2013 to July 2019. Based on treatments, 62 patients were assigned into three groups: Conservative (n=16), PTCD (n=22) and ERCP (n=24) groups. According to different treatment times, PTCD and ERCP groups were further assigned into early PTCD (⩽ 72 h, n=10) and delayed PTCD (>72 h, n=12) groups as well as early ERCP (⩽72 h, n=8) and delayed ERCP (>72 h, n=16) groups. Patients with ABP associated with cholangitis or bile duct obstructions^[23] and who had been subjected to ERCP were included in the ERCP group. Patients who could not tolerate endoscopy due to advanced age, persistent organ failure, multiple concomitant diseases, and clinical deterioration with signs or strong suspicion of infected necrotizing pancreatitis were included in the PTCD group. Patients who could not tolerate PTCD and ERCP/ENBD, as well as those who refused to accept any traumatic therapies were included in the Conservative group. In case the previously scheduled treatments failed, or in case of critical conditions, emergency interventions or surgical treatments were chosen with provision of a written informed consent^[24,25]. The 62 SABP patients were finally enrolled in this study (Table 1; Fig. 1).

View this table:

• View inline
• View popup
• Download powerpoint

Table 1:

Inclusion and exclusion criteria for SABP patients

• Download figure
• Open in new tab

Figure 1:

Flow diagram for this study.

3. Results

4. Discussion

Acute biliary pancreatitis is a common health care challenge in real-world clinical setting^[31]. This condition is majorly caused by gallstones obstructing the biliopancreatic duct; however, persistence obstruction of the ampulla can theoretically aggravate pancreatic inflammation and may cause cascade activation of cytokines that mediates SIRS, pancreas and pancreatic tissue inflammation edema and necrosis^[32,33]. Therefore, obstructive SABP is a clinical emergency with mortality rates of about 15%^[34], requiring prompt recognition and timely intervention to limit morbidity and prevent mortality or recurrence. Studies^[22,35] have shown that relieving biliary obstruction is an important measure for reducing SABP risk, to delay disease progression and improve prognosis.

Biliary obstruction can be eliminated by ERCP, PTCD and laparoscopic cholecystectomy^[36]. Although there is no universally accepted treatment approach for SABP, the step-up approach using endoscopic drainage or percutaneous has been demonstrated to produce superior outcomes^[37]. First, the 2019 Guidelines for management of acute biliary pancreatitis^[38] recommend ERCP for patients with any of the three high-risk criteria of cholangitis, radiological evidence of calculi, and total bilirubin >4 mg/dl combined with bile duct dilation. A meta-analysis^[22] involving 519 patients with pancreatitis and biliary obstruction found that routine use of ERCP reduced local complications. Second, PTCD is a minimally invasive surgical method with high patient cooperation. It is often used as an alternative method for surgical decompression in critically ill patients to relieve bile duct pressure. In this study, we assessed the therapeutic effects of conservative treatment, ERCP and PTCD in obstructive severe acute biliary pancreatitis and the choosing time of ERCP and PTCD. We established that clinical efficacies of ERCP and PTCD for obstructive SABP were comparable and that both approaches are beneficial for recovery of laboratory indicators; patients subjected to ERCP or PTCD had shorter remission times of abdominal pain, hospital stay, lower incidences and mortality of sepsis. Complications due to ERCP and PTCD were fewer than those of conservative treatment. Our findings are consistent with those of previous studies^[21,22,34].

For all gallstone pancreatitis patients with suspected ascending cholangitis, prompt (within 48 h of presentation) ERCP is recommended. Given that there is no consensus on guidelines for obstruction relief of SABP and that emergency ERCP may not always be performed in clinical practice, we evaluated the therapeutic effects of early (⩽ 72 h) and delayed (>72 h) ERCP in ABP patients with cholangitis. In this study, clinical efficacies of early ERCP and PTCD were better than those of delayed ERCP and PTCD. Early endoscopic and interventional therapy is recommended for relieving obstruction of patients with obstructive severe acute biliary pancreatitis within 72 h after admission. Our findings provide an important indication for future prospective studies.

SABP should be managed by intensive monitoring and systemic support. Conservative treatment is aimed at achieving supportive therapy, resuscitation and to treat specific complications that may occur^[39,40]. Conservative therapy is imperative and fundamental for SABP patients. In this study, the clinical efficacies and treatment satisfaction of patients subjected to conservative treatment alone were poor. Since the treatment was not feasible or satisfactory, three patients in the conservative group were eventually treated with ERCP. Due to critical conditions of obstructive SABP, clinicians may be concerned about the risk of conservative medical management. In conclusion, conservative therapy is the basis of obstructive SABP, but timely intervention is reasonable within 72 h for laboratory indices, hospitalization stays, recovery of liver function and remission of abdominal pain and complications. If early ERCP is not safe and feasible, PTCD should be performed and has certain clinical effect.

This study is associated with some limitations. First, surgical risks of patients were not assessed, which could have led to deviations in the success rates of surgeries, subsequent cure rates and postoperative complications among other aspects. Second, the sample size was limited to a single center retrospective study, which may have resulted in the absence of significant differences in recovery rate. Given these limitations, a stricter standard, follow-up visits, high-quality and large sample tests are required to verify the reliability of our conclusions. Further researches are needed and other researchers can use this research to obtain strategies for treatment and management of severe acute biliary pancreatitis.

Conclusions

Removal of obstruction of SABP is a focus of clinical attention. Decision on the timing of procedural interventions is also crucial for improving morbidity or mortality outcomes. In summary, ERCP and PTCD are effective for relieving biliary obstruction of severe acute biliary pancreatitis. Early ERCP or PTCD (within 72 h) for obstructive SABP are more beneficial.